2025年12月3日，堃博医疗控股有限公司（港交所股份代号：2216）公布截至2025年11月30日的股份变动月报。报告显示，公司法定注册股本维持在2,000,000,000股，面值每股USD 0.000025，总额USD 50,000；当月无任何增减变动。
截至2025年11月30日，公司已发行股份（不含库藏股）为526,579,084股，库藏股为1,658,000股，合计528,237,084股；与上月相比并无新增发行或回购注销活动，已发行股份及库藏股数目均保持不变。
在股权激励方面，公司2021年5月9日采纳的股份激励计划项下，期末持有的股份期权合计4,096,960份，当月未有行使、授出或注销。另根据“受限制股份单位计划”，本月亦无派发新股或库藏股转让情况。
公司确认，所有活动均遵照香港联交所《上市规则》及相关法律规定办理。该报告由公司董事徐宏签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.